Rock Springs Capital Management LP Xenon Pharmaceuticals Inc. Transaction History

Rock Springs Capital Management LP

$2.51 Billion
Q4 2024

A detailed history of Rock Springs Capital Management LP transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 1,251,859 shares of XENE stock, worth $49.7 Million. This represents 1.96% of its overall portfolio holdings.

Number of Shares

1,251,859

Previous 1,316,477 4.91%

Holding current value

$49.7 Million

Previous $51.8 Million 5.27%

% of portfolio

1.96%

Previous 1.76%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$38.14 - $45.74 $2.46 Million - $2.96 Million	-64,618 Reduced 4.91%	1,251,859 $49.1 Million
Q3 2024 Nov 14, 2024	BUY	$36.12 - $43.96 $1.57 Million - $1.92 Million	43,600 Added 3.43%	1,316,477 $51.8 Million
Q2 2024 Aug 14, 2024	BUY	$36.25 - $43.75 $627,125 - $756,875	17,300 Added 1.38%	1,272,877 $49.6 Million
Q4 2023 Feb 14, 2024	BUY	$28.7 - $46.46 $2.23 Million - $3.6 Million	77,575 Added 6.59%	1,255,577 $57.8 Million
Q1 2023 May 15, 2023	BUY	$33.46 - $40.35 $77,961 - $94,015	2,330 Added 0.2%	1,178,002 $42.2 Million
Q4 2022 Feb 14, 2023	BUY	$33.06 - $39.43 $651,645 - $777,204	19,711 Added 1.71%	1,175,672 $46.4 Million
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $996,272 - $1.29 Million	32,357 Added 2.88%	1,155,961 $41.7 Million
Q2 2022 Aug 15, 2022	BUY	$25.44 - $35.16 $7.15 Million - $9.88 Million	281,106 Added 33.37%	1,123,604 $34.2 Million
Q1 2022 May 16, 2022	BUY	$25.09 - $33.13 $1.78 Million - $2.36 Million	71,131 Added 9.22%	842,498 $25.8 Million
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $2.94 Million - $6.66 Million	188,267 Added 32.29%	771,367 $24.1 Million
Q3 2021 Nov 15, 2021	BUY	$14.86 - $19.45 $157,516 - $206,170	10,600 Added 1.85%	583,100 $8.91 Million
Q1 2021 May 17, 2021	BUY	$13.65 - $21.31 $784,875 - $1.23 Million	57,500 Added 11.17%	572,500 $10.2 Million
Q4 2020 Feb 16, 2021	SELL	$9.49 - $16.04 $6,747 - $11,404	-711 Reduced 0.14%	515,000 $7.92 Million
Q2 2020 Aug 14, 2020	BUY	$10.21 - $14.9 $160,409 - $234,093	15,711 Added 3.14%	515,711 $6.47 Million
Q1 2020 May 15, 2020	BUY	$8.08 - $17.57 $4.04 Million - $8.79 Million	500,000 New	500,000 $5.67 Million

Others Institutions Holding XENE

# of Institutions

219

Shares Held

70.4M

Call Options Held

109K

Put Options Held

2.1K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.47B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Account

Rock Springs Capital Management LP Xenon Pharmaceuticals Inc. Transaction History